TsiRNAHIV-1

Priti Kumar1, Hong-Seok Ban, Sang-Soo Kim

  • 1Immune Disease Institute and Department of Pediatrics, Harvard Medical School, Boston, MA 02115, USA.

Cell
|August 12, 2008
PubMed
概括

RNA干扰 (RNAi) 疗法在艾滋病毒治疗方面表现有前途. 在临床前模型中,一种新的T细胞特异性传递系统有效地抑制了HIV复制,并防止了CD4 T细胞损失.